The ‘Big Three’ could benefit from the phenomenal strides in vaccine technology

Three historically neglected diseases – the ‘Big Three’, namely tuberculosis, malaria and HIV/AIDS- could be set to benefit from the phenomenal strides that have occurred in vaccine technology in the 2020s.